Kraig Biocraft Laboratories Inc (KBLB): Only replying to your query,namely: I...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: imelcooler post# 100108

Monday, 11/30/2015 6:27:20 PM

Monday, November 30, 2015 6:27:20 PM

Only replying to your query,namely:

I thought CHISPR's big advantage is it doesn't use a protein expression,

You recently posted:

I read this before on this board,and it put me to sleep.

That's why I exposed you to the most pertinent parts,that I felt were adequately comprehensible.

Blessings to All

TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.

Keep Last Read

Replies (1) Next 10 Prev Next

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!